Pulsed Radiofrequency Therapy on Peripheral Nerves Monitoring Pain, Quality of Life, Patient Satisfaction and Efficacy

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

March 4, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

February 28, 2026

Conditions
Neuropathic Pain
Interventions
PROCEDURE

Pulsed Radiofrequency (PRF) Treatment

PRF treatment maintains a temperature below 42°C and does not produce structural tissue damage around the needle. PRF exposure to the Dorsal Root Ganglion (DRG) induces c-Fos gene expression in the dorsal horn, which suggests a cellular response to the electric forces generated within the DRG. PRF has been found to relieve neuropathic pain by inducing long-term depression of synaptic transmission in the spinal cord, leading to a decrease in allodynia and hyperalgesia. It also modulates the inflammatory response in the injured area by decreasing the expression of pro-inflammatory cytokines, such as TNF-α, in the peripheral nerve and spinal cord, which is a major player in the development and maintenance of neuropathic pain. PRF is characterized by a 500 kHz current applied for 2 pulses per second, with each pulse lasting 20 milliseconds.

Trial Locations (1)

1081 HV

RECRUITING

Amsterdam UMC, Amsterdam

All Listed Sponsors
lead

Amsterdam UMC, location VUmc

OTHER